Inactive Instrument

Regent Pacific Group Ltd. Share Price Hong Kong S.E.

Equities

0575

KYG7478U1388

Pharmaceuticals

Financials

Sales 2022 35T 3L 29.23L Sales 2023 3L 22.73L 2.43Cr Capitalization 1.81Cr 14Cr 151.43Cr
Net income 2022 -3.6Cr -28Cr -300.61Cr Net income 2023 -2.5Cr -20Cr -208.76Cr EV / Sales 2022 1,045 x
Net Debt 2022 1.23Cr 9.6Cr 102.64Cr Net cash position 2023 12.2L 95.3L 10Cr EV / Sales 2023 58.1 x
P/E ratio 2022
-0.67 x
P/E ratio 2023
-0.71 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 40.23%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 58 01/96/01
Founder 68 01/90/01
Director of Finance/CFO 49 01/11/01
Members of the board TitleAgeSince
Founder 68 01/90/01
Chief Executive Officer 58 01/96/01
Director/Board Member 80 01/01/01
More insiders
Regent Pacific Group Ltd, formerly Endurance RP Ltd is an investment holding company principally engaged in biopharma and investment businesses. The Company operates its business through two segments. The Biopharma segment is engaged in the research, development, manufacture, marketing and sale of pharmaceutical products. The Corporate Investment segment is engaged in the investment in listed and unlisted corporate entities. The Company is also engaged in aging research and developing artificial intelligence (AI) models and tool products related to aging research. It offers aging and longevity clocks to the longevity clinics, preventative medicine organizations, health clubs, insurance companies, and aging research institutions.
More about the company